Literature DB >> 24260825

Comparative study between the effect of nitazoxanide and paromomycine in treatment of cryptosporidiosis in hospitalized children.

Salah M M Hussien1, Osama H Abdella, Anwar H Abu-Hashim, Gamal A Aboshiesha, Mohamad A A Taha, Ahmed S El-Shemy, Mohamad M El-Bader.   

Abstract

Ninety children infected with Cryptosporidium parvum attending Al-Azhar University Teaching Hospital (Assuit) were chosen (60 males & 30 females) with age range from 6 months to ten years. The patients were divided into two groups of 45 patients for each (G1 & G2). All patients suffered from chronic diarrhea for more than fifteen days. Cross-matched 45 children suffering from chronic diarrhea were used as a control group (G3). Stool samples were collected and examined for detection of Cryptosporidium oocysts using Sheather's sugar and Modified Ziehl-Nelseen stain techniques. The first group (G1) received Nitazoxanide (100 mg and 200 mg every 12 hours for 3 days for children aged 6 months to 3 years and chil dren aged 4 to 10 years respectively), G2 received Paromomycin (25 mg/kg/day for 2 weeks). Third group received placebo. Significant improvement and shortening of the duration of diarrhea occur in G1; of 45 patients received Nitazoxanide 39 cases showed complete clinical and laboratory cure (86.6%), 5 cases showed clinical improvement with reduction in the number of oocysts and 1 case showed no cure. In G2 of 45 cases received Paromomycin 31 cases showed complete cure (68.8%), 8 cases showed clinical improvement with reduction of oocysts number and 6 cases were not cured. Nitazoxanide proved highly effective than Paromomycin in cryptosporidiosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24260825

Source DB:  PubMed          Journal:  J Egypt Soc Parasitol        ISSN: 1110-0583


  8 in total

Review 1.  Understanding drug resistance in human intestinal protozoa.

Authors:  Hend Aly El-Taweel
Journal:  Parasitol Res       Date:  2015-03-19       Impact factor: 2.289

Review 2.  Cryptosporidium: Still Open Scenarios.

Authors:  Stefania Pane; Lorenza Putignani
Journal:  Pathogens       Date:  2022-04-26

3.  Treatment of Cryptosporidium: What We Know, Gaps, and the Way Forward.

Authors:  Hayley Sparks; Gayatri Nair; Alejandro Castellanos-Gonzalez; A Clinton White
Journal:  Curr Trop Med Rep       Date:  2015-08-01

4.  Nitazoxanide in the Treatment of Intestinal Parasitic Infections in Children: A Systematic Review and Meta-Analysis.

Authors:  Jinyi Li; Hongyu Kuang; Xue Zhan
Journal:  Indian J Pediatr       Date:  2019-12-12       Impact factor: 1.967

Review 5.  Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Authors:  M Schmidt-Hieber; J Bierwirth; D Buchheidt; O A Cornely; M Hentrich; G Maschmeyer; E Schalk; J J Vehreschild; Maria J G T Vehreschild
Journal:  Ann Hematol       Date:  2017-11-24       Impact factor: 3.673

6.  NMR metabolomics reveals effects of Cryptosporidium infections on host cell metabolome.

Authors:  Christopher N Miller; Charalampos G Panagos; William R T Mosedale; Martin Kváč; Mark J Howard; Anastasios D Tsaousis
Journal:  Gut Pathog       Date:  2019-04-03       Impact factor: 4.181

7.  A Proposed Target Product Profile and Developmental Cascade for New Cryptosporidiosis Treatments.

Authors:  Christopher D Huston; Thomas Spangenberg; Jeremy Burrows; Paul Willis; Timothy N C Wells; Wesley van Voorhis
Journal:  PLoS Negl Trop Dis       Date:  2015-10-08

Review 8.  Drug Development Against the Major Diarrhea-Causing Parasites of the Small Intestine, Cryptosporidium and Giardia.

Authors:  Yukiko Miyamoto; Lars Eckmann
Journal:  Front Microbiol       Date:  2015-11-19       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.